GRAL
GRAIL Inc.

1,773
Mkt Cap
$3.31B
Volume
1.12M
52W High
$103.00
52W Low
$13.24
PE Ratio
-7.11
GRAL Fundamentals
Price
$91.93
Prev Close
$91.15
Open
$91.29
50D MA
$56.99
Beta
2.36
Avg. Volume
912,319.76
EPS (Annual)
-$59.81
P/B
1.43
Rev/Employee
$125,595.00
Loading...
Loading...
News
all
press releases
GRAIL to Announce Third Quarter 2025 Financial Results
GRAIL to Announce Third Quarter 2025 Financial Results GRAIL to Announce Third Quarter 2025 Financial Results PR Newswire MENLO PARK, Calif., Oct. 29, 2025 Analyst Day 2025 Webcast to Begin at 11:00...
PR Newswire·4d ago
News Placeholder
More News
News Placeholder
Why Is GRAL Stock Rising Today?
Stocktwits·13d ago
News Placeholder
GRAIL PATHFINDER 2 Results Show Galleri Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings
GRAIL PATHFINDER 2 Results Show Galleri Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings GRAIL PATHFINDER 2...
PR Newswire·16d ago
News Placeholder
Precision Oncology Approaches Drive $312B Market Transformation
Precision Oncology Approaches Drive $312B Market Transformation Precision Oncology Approaches Drive $312B Market Transformation PR Newswire VANCOUVER, Oct. 17, 2025 USA News Group News Commentary...
PR Newswire·16d ago
News Placeholder
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri Multi-Cancer Early Detection Test to Asia
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri Multi-Cancer Early Detection Test to Asia Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri...
PR Newswire·17d ago
News Placeholder
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of -36.36% and -2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates
Femasys (FEMY) delivered earnings and revenue surprises of +11.11% and -48.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates
Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of -11.11% and +1.96%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Stock Market News for May 23, 2025
Zacks·5mo ago
News Placeholder
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise...
PR Newswire·8mo ago

Latest GRAL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.